Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment
Alexander J. Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (2020) Vol. 128, pp. 83-102
Closed Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
Luca Fania, Dario Didona, Francesca Romana Di Pietro, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 171-171
Open Access | Times Cited: 179
Non-Melanoma Skin Cancers: Biological and Clinical Features
Mauro Cives, Francesco Mannavola, Lucia Lospalluti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5394-5394
Open Access | Times Cited: 159
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
Brett Hughes, Eva Muñoz‐Couselo, Laurent Mortier, et al.
Annals of Oncology (2021) Vol. 32, Iss. 10, pp. 1276-1285
Open Access | Times Cited: 134
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022
Chrysalyne D. Schmults, Rachel Blitzblau, Sumaira Z. Aasi, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 12, pp. 1382-1394
Open Access | Times Cited: 105
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019)
A. James P. Clover, Francesca De Terlizzi, Giulia Bertino, et al.
European Journal of Cancer (2020) Vol. 138, pp. 30-40
Closed Access | Times Cited: 92
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
Alice Baggi, Pietro Quaglino, Marco Rubatto, et al.
European Journal of Cancer (2021) Vol. 157, pp. 250-258
Closed Access | Times Cited: 84
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
Advances in Therapy (2022) Vol. 39, Iss. 3, pp. 1164-1178
Open Access | Times Cited: 53
Skin cancer: Primary, secondary, and tertiary prevention. Part II.
Kristina D. Rojas, Mariana Enriqueta Pérez Pérez, Michael A. Marchetti, et al.
Journal of the American Academy of Dermatology (2022) Vol. 87, Iss. 2, pp. 271-288
Closed Access | Times Cited: 41
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023
Alexander J. Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113252-113252
Open Access | Times Cited: 36
European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023
Alexander J. Stratigos, Claus Garbe, Clio Dessinioti, et al.
European Journal of Cancer (2023) Vol. 193, pp. 113251-113251
Open Access | Times Cited: 35
Squamous-Cell Carcinoma of the Skin
Ashley Wysong
New England Journal of Medicine (2023) Vol. 388, Iss. 24, pp. 2262-2273
Closed Access | Times Cited: 30
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol
Karlijn Verkerk, Birgit S. Geurts, Laurien J. Zeverijn, et al.
The Lancet Regional Health - Europe (2024) Vol. 39, pp. 100875-100875
Open Access | Times Cited: 13
Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer
Jinyuan Ma, Zongguang Tai, Ying Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2057-2070
Open Access | Times Cited: 10
METTL1 coordinates cutaneous squamous cell carcinoma progression via the m7G modification of the ATF4 mRNA
Xinru Zhang, Tong Chen, Fanrong Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma
Arnold Lee, Sean T. Duggan, Emma D. Deeks
Drugs (2020) Vol. 80, Iss. 8, pp. 813-819
Closed Access | Times Cited: 66
Update of the Management of Cutaneous Squamous-cell Carcinoma
E. Maubec
Acta Dermato Venereologica (2020) Vol. 100, Iss. 11, pp. adv00143-adv00143
Open Access | Times Cited: 64
The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma
Minna Piipponen, Pilvi Riihilä, Liisa Nissinen, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4507-4507
Open Access | Times Cited: 53
Line‐field confocal optical coherence tomography for actinic keratosis and squamous cell carcinoma: a descriptive study
Élisa Cinotti, Linda Tognetti, Alessandra Cartocci, et al.
Clinical and Experimental Dermatology (2021) Vol. 46, Iss. 8, pp. 1530-1541
Open Access | Times Cited: 48
Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
Barbara Bailly-Caillé, D. Kottler, Rémy Morello, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 495-495
Open Access | Times Cited: 20
Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers—Emerging Strategies for Clinical Management
Carla Ferrándiz‐Pulido, Ulrike Leiter, Catherine Α. Harwood, et al.
Transplantation (2023) Vol. 107, Iss. 7, pp. 1452-1462
Closed Access | Times Cited: 20
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
Marco Rubatto, Nadia Sciamarrelli, Silvia Borriello, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 19
Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma
Ying Li, Zongguang Tai, Jinyuan Ma, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 19
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma
Philip R. Clingan, Rahul Ladwa, Daniel Brungs, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 10, pp. e007637-e007637
Open Access | Times Cited: 17
Molecular targeted therapies for cutaneous squamous cell carcinoma: recent developments and clinical implications.
H. B. Singh, Hitesh Chopra, Inderbir Singh, et al.
PubMed (2024) Vol. 23, pp. 300-334
Closed Access | Times Cited: 7
Update of advanced cutaneous squamous cell carcinoma
Estella de Jong, M.U.P.A. Lammerts, Roel E. Genders, et al.
Journal of the European Academy of Dermatology and Venereology (2021) Vol. 36, Iss. S1, pp. 6-10
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top